Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trial.
- DOI
- 10.1016/s2352-4642(26)00098-2
- Published
- 2026 Aug
- Container
- The Lancet. Child & adolescent health
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-4642-26-00098-2,
title = {Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trial.},
author = {Molin S and Baselga E and Navarro-Triviño FJ and Reguiai Z and Schepper S and Halpern J and Marcoux D and Su JC and Brzewski P and Antonsen SD and Hiort LC and Søhoel A and Thøgersen P and Rubel D},
year = {2026},
journal = {The Lancet. Child \& adolescent health},
doi = {10.1016/s2352-4642(26)00098-2},
url = {https://doi.org/10.1016/s2352-4642(26)00098-2}
}RIS
TY - JOUR TI - Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trial. AU - Molin S AU - Baselga E AU - Navarro-Triviño FJ AU - Reguiai Z AU - Schepper S AU - Halpern J AU - Marcoux D AU - Su JC AU - Brzewski P AU - Antonsen SD AU - Hiort LC AU - Søhoel A AU - Thøgersen P AU - Rubel D PY - 2026 JO - The Lancet. Child & adolescent health DO - 10.1016/s2352-4642(26)00098-2 UR - https://doi.org/10.1016/s2352-4642(26)00098-2 ER -
APA
S, M., E, B., FJ, N., Z, R., S, S., J, H., D, M., JC, S., P, B., SD, A., LC, H., A, S., P, T., & D, R. (2026). Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trial.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(26)00098-2
Source records
- pubmed · retrieved 2026-09-26T00:57:48.370Z